Cardiosense
Latest round
- Series A
Last raised
- Nov 2022
Total raised
- $9.1M
Investors
- 6
About Cardiosense
Based in the US, Cardiosense, Inc.Cardiosense, Inc. is focused on cardiac health management, providing cutting-edge solutions for early disease detection. The company is headquartered in Chicago, US.Cardiosense offers an advanced digital biomarker platform that integrates innovative, multi-sensor wearable devices and proprietary algorithms designed to identify early signs of cardiac disease and facilitate personalized therapy. Their flagship product, the CardioTag Sensor, is a medical-grade wearable device capable of wireless monitoring of patients, providing a seamless transition from in-hospital to home care. This device works in conjunction with the Wavesense Platform, a device-agnostic software solution that aggregates, transmits, and analyzes physiological sensor data, effectively mining raw biosignals for improved visibility into cardiac function. Through the application of deep learning algorithms to raw physiological waveforms, Cardiosense develops digital biomarkers targeted at early disease detection, which ultimately aims to enhance patient care.Cardiosense’s revenue structure is based on a combination of direct sales, subscription models, and partnerships with healthcare providers and institutions. Transactions typically occur through B2B relationships where hospitals and clinics acquire their CardioTag Sensors along with access to the Wavesense Platform for an integrated patient monitoring solution. These clients may engage in annual subscription agreements to access continuous software updates and analytics features, providing ongoing value beyond initial device sales. The company’s products cater to a specialized segment within the healthcare market, focusing on cardiac disease management, emphasizing the importance of their offerings in enhancing patient outcomes.In November 2022, Cardiosense, Inc. The company plans to expand its offerings, including the development of upcoming products aimed at enhancing cardiac health management. They are strategically targeting growth in North America and Europe, with plans to increase their market presence significantly by the end of 2023.
Who invested in Cardiosense
6 investors across 1 round
See all investors in Cardiosense
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 29, 2022
Amount
$9.1M
Investors
Questions about Cardiosense
Who invested in Cardiosense?
Cardiosense has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cardiosense raised?
Cardiosense has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cardiosense last raise money?
Cardiosense's most recent round on record is a Series A, in Nov 2022.
What does Cardiosense do?
Based in the US, Cardiosense, Inc.
Where is Cardiosense headquartered?
Cardiosense is headquartered in Chicago, US.
Which VCs invest in companies like Cardiosense?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Cardiosense's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series A
Raising like Cardiosense? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.